TriMas (NASDAQ:TRS) Releases FY 2025 Earnings Guidance

TriMas (NASDAQ:TRS - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.700-1.850 for the period, compared to the consensus estimate of 1.770. The company issued revenue guidance of $962.0 million-$980.5 million, compared to the consensus revenue estimate of $973.9 million.

Wall Street Analysts Forecast Growth

Separately, BWS Financial reiterated a "buy" rating and issued a $40.00 target price on shares of TriMas in a research note on Wednesday.

TriMas Stock Performance

TRS traded up $0.55 during midday trading on Friday, hitting $24.75. 407,166 shares of the company were exchanged, compared to its average volume of 319,470. TriMas has a 1-year low of $19.33 and a 1-year high of $28.51. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $1.01 billion, a price-to-earnings ratio of 38.67 and a beta of 0.55. The company's 50 day simple moving average is $22.42 and its 200 day simple moving average is $24.33.

TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.03. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The company had revenue of $241.67 million during the quarter, compared to analysts' expectations of $235.41 million. During the same quarter in the previous year, the company earned $0.37 earnings per share. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. As a group, sell-side analysts predict that TriMas will post 1.69 earnings per share for the current year.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th will be given a dividend of $0.04 per share. The ex-dividend date of this dividend is Tuesday, May 6th. This represents a $0.16 annualized dividend and a dividend yield of 0.65%. TriMas's dividend payout ratio (DPR) is presently 27.12%.

Insider Transactions at TriMas

In other TriMas news, Director Shawn Sedaghat bought 249,597 shares of TriMas stock in a transaction on Friday, March 7th. The shares were bought at an average price of $23.83 per share, for a total transaction of $5,947,896.51. Following the completion of the transaction, the director now directly owns 346,825 shares of the company's stock, valued at $8,264,839.75. This trade represents a 256.71 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Jeffrey A. Fielkow purchased 2,500 shares of the stock in a transaction dated Friday, February 28th. The shares were acquired at an average price of $20.78 per share, with a total value of $51,950.00. Following the completion of the acquisition, the director now owns 11,013 shares in the company, valued at approximately $228,850.14. This trade represents a 29.37 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought 929,634 shares of company stock valued at $22,278,549 over the last ninety days. Insiders own 14.20% of the company's stock.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.